Effects of 5alpha-reduced androgens on preputial-gland size and lipogenic activity.
D015113:Androstane-3,17-diol / Q000494:pharmacology*; D000731:Androstanes / Q000494:pharmacology*; D000818:Animals; D013196:Dihydrotestosterone / Q000494:pharmacology*; D007016:Hypophysectomy; D008055:Lipids / Q000096:biosynthesis*; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology; D009929:Organ Size; D010413:Penis; D011467:Prostate / Q000033:anatomy & histology / Q000187:drug effects; D051381:Rats; D012627:Sebaceous Glands / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism*; D012669:Seminal Vesicles / Q000033:anatomy & histology / Q000187:drug effects; D013185:Squalene / Q000096:biosynthesis; D014885:Waxes / Q000378:metabolism
D000731:Androstanes; D008055:Lipids; D014885:Waxes; D013196:Dihydrotestosterone; D015113:Androstane-3,17-diol; D013185:Squalene; D009074:Melanocyte-Stimulating Hormones